Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.
Frequently asked questions
What sector does Claritas Pharmaceuticals Inc (CLAZF) operate in?
Claritas Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Claritas Pharmaceuticals Inc (CLAZF) current stock price?
As of the latest data, Claritas Pharmaceuticals Inc stock price is $0.00, with a previous close of $0.00.
What is Claritas Pharmaceuticals Inc (CLAZF) current market capitalization?
Claritas Pharmaceuticals Inc market cap is approximately 3.66 thousand.
Does Claritas Pharmaceuticals Inc (CLAZF) pay dividends?
No. Claritas Pharmaceuticals Inc does not pay a dividend.
What is Claritas Pharmaceuticals Inc (CLAZF) beta (volatility) score?
Claritas Pharmaceuticals Inc has a beta of 34.228, indicating very high volatility compared to the market.